Belimumab after rituximab as maintenance therapy in lupus nephritis

被引：51
|
作者：
Kraaij, Tineke [1 ]
Huizinga, Tom W. J. [2 ]
Rabelink, Ton J. [1 ]
Teng, Y. K. Onno [1 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands
来源：
RHEUMATOLOGY | 2014年 / 53卷 / 11期
关键词：
ERYTHEMATOSUS; EFFICACY;
D O I：
10.1093/rheumatology/keu369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2122 / 2124
页数：4
相关论文
共 50 条
  • [21] Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares
    Zisa, Diane
    Zhang-Sun, Jeffrey
    Christos, Paul J.
    Kirou, Kyriakos A.
    LUPUS, 2024, 33 (09) : 938 - 947
  • [22] Adding belimumab improves lupus nephritis
    Sarah Onuora
    Nature Reviews Rheumatology, 2020, 16 : 601 - 601
  • [23] New Protocols for Treatment of Class IV Lupus Nephritis with Emphasis on Rituximab as the Sole Maintenance Therapy
    El-Reshaid, Kamel
    El-Reshaid, Wael
    Al-Bader, Shaikha
    Sallam, Hossameldin Tawfik
    Hakim, Abbass Ali
    Al-Attiyah, Rajaa
    KUWAIT MEDICAL JOURNAL, 2018, 50 (03): : 343 - 350
  • [24] Belimumab for systemic lupus erythematosus - Focus on lupus nephritis
    Pluess, Marlene
    Piantoni, Silvia
    Tampe, Bjoern
    Kim, Alfred H. J.
    Korsten, Peter
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [25] Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence
    Manuel Ramos-Casals
    Candido Diaz-Lagares
    Maria-Jose Soto-Cardenas
    Pilar Brito-Zeron
    María-José Cuadrado
    Giovanni Sanna
    Laura Bertolaccini
    Munther A. Khamashta
    Clinical Reviews in Allergy & Immunology, 2011, 40 : 159 - 169
  • [26] Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence
    Ramos-Casals, Manuel
    Diaz-Lagares, Candido
    Soto-Cardenas, Maria-Jose
    Brito-Zeron, Pilar
    Cuadrado, Maria-Jose
    Sanna, Giovanni
    Bertolaccini, Laura
    Khamashta, Munther A.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2011, 40 (03) : 159 - 169
  • [27] Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
    Atisha-Fregoso, Yemil
    Malkiel, Susan
    Harris, Kristina M.
    Byron, Margie
    Ding, Linna
    Kanaparthi, Sai
    Barry, William T.
    Gao, Wendy
    Ryker, Kristin
    Tosta, Patti
    Askanase, Anca D.
    Boackle, Susan A.
    Chatham, W. Winn
    Kamen, Diane L.
    Karp, David R.
    Kirou, Kyriakos A.
    Sam Lim, S.
    Marder, Bradley
    McMahon, Maureen
    Parikh, Samir V.
    Pendergraft, William F., III
    Podoll, Amber S.
    Saxena, Amit
    Wofsy, David
    Diamond, Betty
    Smilek, Dawn E.
    Aranow, Cynthia
    Dall'Era, Maria
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (01) : 121 - 131
  • [28] Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis
    Davies, R. J.
    Sangle, S. R.
    Jordan, N. P.
    Aslam, L.
    Lewis, M. J.
    Wedgwood, R.
    D'Cruz, D. P.
    LUPUS, 2013, 22 (06) : 574 - 582
  • [29] Induction and maintenance therapy in proliferative lupus nephritis
    Ponticelli, Claudio
    Glassock, Richard J.
    Moroni, Gabriella
    JOURNAL OF NEPHROLOGY, 2010, 23 (01) : 9 - 16
  • [30] Multitarget Therapy for Maintenance Treatment of Lupus Nephritis
    Zhang, Haitao
    Liu, Zhengzhao
    Zhou, Minlin
    Liu, Zhangsuo
    Chen, Jianghua
    Xing, Changying
    Lin, Hongli
    Ni, Zhaohui
    Fu, Ping
    Liu, Fuyou
    Chen, Nan
    He, Yongcheng
    Liu, Jianshe
    Zeng, Caihong
    Liu, Zhihong
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (12): : 3671 - 3678
12345